Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

463 companies

Ticker ▴	Company	Revenue	Net income	Net margin	Return on equity	Revenue growth	Diluted EPS
AARD	Aardvark Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$57.59M	n/a	-54.0%	n/a	-$2.93
ABBV	AbbVie Inc. Manufacturing · Year ended 2025-12-31 · USD	$61.16B	$4.23B	6.9%	n/a	8.6%	$2.36
ABCL	AbCellera Biologics Inc. Manufacturing · Year ended 2025-12-31 · USD	$75.13M	-$146.41M	-194.9%	-15.1%	160.6%	-$0.49
ABEO	Abeona Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	$71.18M	n/a	44.7%	n/a	$1.01
ABT	Abbott Laboratories Manufacturing · Year ended 2025-12-31 · USD	$44.33B	$6.52B	14.7%	12.5%	5.7%	$3.72
ABUS	Arbutus Biopharma Corp Manufacturing · Year ended 2025-12-31 · USD	$14.08M	-$33.50M	-237.9%	-43.7%	128.2%	-$0.17
ABVC	Abvc Biopharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	$296.0K	-$7.91M	n/m	-71.2%	-41.9%	-$0.39
ACAD	Acadia Pharmaceuticals Inc Manufacturing · Year ended 2025-12-31 · USD	$1.07B	$391.00M	36.5%	31.9%	11.9%	$2.30
ACET	Adicet Bio, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$116.80M	n/a	-73.4%	n/a	-$16.95
ACRS	Aclaris Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$7.83M	-$64.92M	-829.6%	-63.0%	-58.2%	-$0.53
ACRV	Acrivon Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$77.91M	n/a	-69.2%	n/a	-$2.02
ACTU	Actuate Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$22.23M	n/a	-280.5%	n/a	-$1.06
ACUT	Accustem Sciences Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$1.76M	n/a	n/a	n/a	-$0.12
ACXP	Acurx Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$7.97M	n/a	-151.2%	n/a	-$5.32
ADAG	Adagene Inc. Manufacturing · Year ended 2025-12-31 · USD	$7.67M	-$17.61M	-229.6%	-49.8%	n/m	-$0.30
ADCT	ADC Therapeutics SA Manufacturing · Year ended 2025-12-31 · USD	$81.36M	-$142.62M	-175.3%	n/a	14.9%	-$1.12
ADIL	Adial Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$7.98M	n/a	-151.2%	n/a	-$11.93
ADTX	Aditxt, Inc. Manufacturing · Year ended 2025-12-31 · USD	$3.2K	-$43.10M	n/m	-768.3%	-97.6%	-$1153.83
AEON	AEON Biopharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$39.22M	n/a	n/a	n/a	-$3.95
AGIO	Agios Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$54.03M	-$412.78M	-764.0%	-34.6%	48.0%	-$7.12
AKBA	Akebia Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$236.20M	-$5.34M	-2.3%	-16.4%	47.5%	-$0.02
AKTX	Akari Therapeutics Plc Manufacturing · Year ended 2025-12-31 · USD	n/a	-$17.30M	n/a	-61.1%	n/a	$0.00
ALDX	Aldeyra Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$33.85M	n/a	-76.5%	n/a	-$0.56
ALKS	Alkermes plc. Manufacturing · Year ended 2025-12-31 · USD	$1.48B	$241.66M	16.4%	13.3%	-5.2%	$1.43
ALLR	Allarity Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$320.0K	-$11.23M	n/m	-114.3%	n/a	n/a

Rows per page: 2550 100